Advanced Search

Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.

Grade Last Price % Change Price Change
B 13.34 -11.83% -1.79
VRCA closed down 11.83 percent on Thursday, March 4, 2021, on 1.24 times normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical VRCA trend table...
Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Crossed Above 20 DMA Bullish -11.83%
Pocket Pivot Bullish Swing Setup -11.83%
Fell Below 20 DMA Bearish -6.45%
Crossed Above 20 DMA Bullish -6.84%
Narrow Range Bar Range Contraction -6.84%
NR7 Range Contraction -6.84%
Fell Below 20 DMA Bearish -2.70%
Wide Bands Range Expansion -6.06%
Wide Bands Range Expansion -12.01%
Older End-of-Day Signals for VRCA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Lower Bollinger Band about 6 hours ago
60 Minute Opening Range Breakdown about 6 hours ago
Down 10% about 6 hours ago
3x Volume Pace about 9 hours ago
Fell Below Previous Day's Low about 9 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Pharmaceutical Industry Pharmaceutical Products Medication Clinical Trial Skin Diseases Common Warts Treatment Of Skin Diseases

Is VRCA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 3 Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference
Feb 23 Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference
Feb 18 Vectoring Back In On Verrica Pharmaceuticals
Feb 17 FDA accepts Verrica's VP-102 NDA resubmission for review
Feb 17 Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Feb 11 The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Jan 19 Verrica's stock surges on positive data from late-stage VP-102 trials
Jan 19 Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
Dec 24 Verrica Pharma perks up after H.C. Wainwright raised price target
Dec 24 Biggest Price Target Changes For Thursday
See more VRCA news...

Indicators

Indicator Value
52 Week High 16.61
52 Week Low 6.02
Average Volume 81,410
200-Day Moving Average 10.19
50-Day Moving Average 12.92
20-Day Moving Average 14.48
10-Day Moving Average 14.38
Average True Range 1.21
ADX 32.1
+DI 26.24
-DI 19.29
Chandelier Exit (Long, 3 ATRs ) 12.99
Chandelier Exit (Short, 3 ATRs ) 15.54
Upper Bollinger Band 15.86
Lower Bollinger Band 13.09
Percent B (%b) 0.09
BandWidth 19.15
MACD Line 0.40
MACD Signal Line 0.58
MACD Histogram -0.1855
Fundamentals Value
Market Cap 344.37 Million
Num Shares 25.8 Million
EPS -1.12
Price-to-Earnings (P/E) Ratio -11.90
Price-to-Sales 0.00
Price-to-Book 6.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.77
Resistance 3 (R3) 15.98 15.37 15.37
Resistance 2 (R2) 15.37 14.75 15.27 15.23
Resistance 1 (R1) 14.36 14.37 14.06 14.15 15.09
Pivot Point 13.75 13.75 13.60 13.65 13.75
Support 1 (S1) 12.74 13.13 12.44 12.53 11.59
Support 2 (S2) 12.13 12.75 12.03 11.45
Support 3 (S3) 11.12 12.13 11.32
Support 4 (S4) 10.91